Michael Sinden
Trial Manager
I joined the Primary Care Clinical Trials Unit in 2022 as a trial coordinator for the site set-up team on the PANORAMIC trial, which was an adaptive platform trial investigating early treatments for COVID-19. Recruiting nearly 30,000 participants, PANORAMIC was the largest trial of a therapeutic agent for COVID-19 in primary care. Later in 2022 I moved to the Oxford Respiratory Trials Unit as an assistant trial manager with the PANORAMIC safety team where, alongside the Clinical Safety Monitor, I managed safety reporting and compliance.
Returning to the CTU in 2024 I am the trial manager for the FOCUS study, which, in collaboration with the University’s Psychiatry Department, is exploring whether a new treatment for psychosis improves cognitive symptoms in people living with schizophrenia, schizoaffective disorder or schizophreniform disorder.